Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
Top Cited Papers
- 1 March 2004
- Vol. 22 (23-24) , 3136-3143
- https://doi.org/10.1016/j.vaccine.2004.01.058
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 responseJournal of General Virology, 2003
- Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartmentsEuropean Journal of Immunology, 2002
- Influenza Revaccination of Elderly Travelers: Antibody Response to Single Influenza Vaccination and Revaccination at 12 WeeksThe Journal of Infectious Diseases, 2001
- Influenza VaccinesDrugs, 1997
- CpG‐containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: A new class of vaccine adjuvantsEuropean Journal of Immunology, 1997
- CpG motifs in bacterial DNA trigger direct B-cell activationNature, 1995
- Adhesion-mediated enhancement of the adjuvant activity of alumVaccine, 1993
- Viral Respiratory Disease at Lowry Air Force Base in Denver, 1952-1982The Journal of Infectious Diseases, 1983
- Antigenic Drift and Efficacy of Influenza Virus Vaccines, 1976-1977The Journal of Infectious Diseases, 1978
- Temperature-Sensitive Mutants of Influenza Virus. IV. Induction of Interferon in the Nasopharynx by Wild-Type and a Temperature-Sensitive Recombinant VirusThe Journal of Infectious Diseases, 1973